Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Popular Weight Loss Drugs Now for Patients With Cancer?
Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes. But data on the practice remain limited.
Weight loss drugs are rising in popularity, but they do carry risks
We know there are several physical risks associated with the drugs, but some are now beginning to question whether there are mental risks.
Taking Weight Loss Drugs? Beware Of These Deadly Mistakes You May Be Making, According To Experts
GLP-1 medicines like Ozempic, Wegovy, and Zepbound – popular across the US, help you shed pounds, but only if taken properly. According to experts, most of the people who take these weight loss drugs without consulting their doctor,
7 Mistakes People Make While Taking Weight Loss Drugs, According to Experts
GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught making these semaglutide slip-ups.
Opinion
Jarvis: High weight loss drug costs hurt
On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic
Are new frozen meals for weight-loss drugs worth it?
Nestle launched frozen meals tailored for people on weight-loss drugs like Ozempic and Wegovy. We tried the teriyaki chicken to see how it tastes.
New weight loss drugs could be developed much faster if Roche gets its way
Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop new drugs, including its slate of experimental weight loss and diabetes medications.
2d
on MSN
WeightWatchers CEO who oversaw diet company’s move into weight loss drugs abruptly leaves role
WeightWatchers is shaking up its leadership. WW International on Friday announced that CEO Sima Sistani would leave her role ...
4d
Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
5d
Weight loss drugs like Ozempic and Wegovy are tremendously popular and effective. Patients should also be careful in using them
Semaglutide, the underlying drug marketed as Ozempic and Wegovy, works by mimicking a hormone that triggers the body to feel ...
3d
on MSN
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
3d
on MSN
Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
3d
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...
Barchart on MSN
11h
This Weight-Loss Stock Just Scored a New Street-High Price Target
Demand forweight-loss drugs has grown at an astonishing rate in recent years, driving share prices of healthcare giants such ...
STAT
11h
Roche seeks to project confidence on its obesity drugs — and sees room to make its mark
Roche argued that its obesity medications would prove to have advantages over its rivals’ — and that the demand for weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
New York
Eli Lilly and Company
Sima Sistani
Feedback